Doctors Consider Convalescent T Cell Therapy for COVID-19
Doctors Consider Convalescent T Cell Therapy for COVID-19
Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.
Doctors Consider Convalescent T Cell Therapy for COVID-19
Doctors Consider Convalescent T Cell Therapy for COVID-19

Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.

Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.

cell therapy
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
CAR T Cells Derived from Stem Cells Target HIV Tissue Reservoirs in Monkeys
Berly McCoy, PhD | May 25, 2021
Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.
Engineered Immune Cells Eliminate Brain Cancer in Mice
Engineered Immune Cells Eliminate Brain Cancer in Mice
Brooke Dulka, PhD | May 25, 2021
Researchers developed a new CAR T-cell therapy that targets specific growth factor receptors in glioblastoma to eliminate brain tumors.
Environmental Cues Keep CAR T Cells on Track
Environmental Cues Keep CAR T Cells on Track
Aparna Nathan | May 25, 2021
Pairing CARs with a synthetic receptor makes T cells more lethal tumor killers.
<em>The Scientist&nbsp;</em>Speaks Ep. 13 - The Long Haul: Improving Cardiac Cell Therapy Persistence
The Scientist Speaks Ep. 13 - The Long Haul: Improving Cardiac Cell Therapy Persistence
The Scientist Creative Services Team | Jan 26, 2021
Researchers remuscularize the heart after cardiac infarction with stem cell-derived cardiomyocytes and ready-made microvessels.
CRISPR Technologies for the New Era of Cell and Gene Therapy
CRISPR Technologies for the New Era of Cell and Gene Therapy
The Scientist Creative Services Team | Nov 25, 2020
Experts will discuss how they use new CRISPR technologies to advance their cell and gene therapy research.
Adoptive Cell Therapy Summit
Adoptive Cell Therapy Summit
The Scientist Creative Services Team | Aug 24, 2020
Join us to learn about adoptive cell therapies from leading experts in the field of cancer immunology. 
Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
Are Mesenchymal Stem Cells a Promising Treatment for COVID-19?
Ruth Williams | Apr 9, 2020
As the first clinical data become available on treating coronavirus patients with the cells, scientists are equivocal about the rationale for the intervention.
Side Effect of CAR T Therapy Caused by Pyroptosis: Mouse Study
Side Effect of CAR T Therapy Caused by Pyroptosis: Mouse Study
Kerry Grens | Jan 20, 2020
The immunotherapy induces a form of cell death in leukemia cells in mice that triggers cytokine release syndrome, a dangerous inflammatory reaction that occurs in some patients.
Gene Editing Makes Cells Evade Immune Attack In Vitro
Gene Editing Makes Cells Evade Immune Attack In Vitro
Emma Yasinski | Dec 12, 2019
To advance the possibility of off-the-shelf cardiac cell therapies, scientists devise an engineered cardiac stem cell that avoids stimulating a detrimental immune attack.
Neural Stem Cell Transplantation Crawls Toward the Clinic
Neural Stem Cell Transplantation Crawls Toward the Clinic
Ashley P. Taylor | Oct 29, 2019
Several early-stage clinical trials indicate that implanting patients with the cells is safe. But whether they can alleviate neurological problems remains to be seen.
Judge Says FDA Can Stop Clinic from Selling Stem Cell Treatments
Judge Says FDA Can Stop Clinic from Selling Stem Cell Treatments
Emma Yasinski | Jun 7, 2019
The decision may facilitate the agency cracking down more effectively on the unproven interventions these companies sell.
Opinion: Ethical Challenges in Using iPS Cells to Treat Paralysis
Opinion: Ethical Challenges in Using iPS Cells to Treat Paralysis
John D. Loike, Martin Grumet | Mar 7, 2019
Uncertainties about the cells’ risk profiles and the potential for hyping unproven therapies mean scientists and the media must tread carefully.
The Biggest Science News of 2018
The Biggest Science News of 2018
Kerry Grens | Dec 27, 2018
From disastrous scientific setbacks to the upending of scientific dogma and the end of a 40-year search for a protein
Journals Retract 13 Papers from Heart Stem Cell Lab
Journals Retract 13 Papers from Heart Stem Cell Lab
Kerry Grens | Dec 14, 2018
It’s the latest fallout from an investigation by Harvard and Brigham and Women’s into work overseen by Piero Anversa.
Increasing Number of iPS Cell Therapies Tested in Clinical Trials
Increasing Number of iPS Cell Therapies Tested in Clinical Trials
Katarina Zimmer | Nov 28, 2018
Since their discovery in 2006, induced pluripotent stem cells have been poised to reprogram regenerative medicine. Twelve years on, here’s how far they’ve come.
Parkinson&rsquo;s Patient Transplanted with Neurons Derived from iPSCs
Parkinson’s Patient Transplanted with Neurons Derived from iPSCs
Ashley P. Taylor | Nov 14, 2018
This is the first time researchers have tested the use of the reprogrammed stem cells in the human brain.
Heart Cell Therapy Trial Paused After Fraud Allegations
Heart Cell Therapy Trial Paused After Fraud Allegations
Ashley P. Taylor | Oct 30, 2018
A trial to test whether so-called c-kit cardiac stem cells, first reported by Piero Anversa, could help patients with chronic heart failure has been halted in light of suspicion surrounding his work.
Cell and Gene Therapy Tracker: Global CAR T-Cell Trials
Cell and Gene Therapy Tracker: Global CAR T-Cell Trials
The Scientist Staff | Aug 22, 2018
Investigators have launched numerous clinical trials that test the efficacy of the immunotherapy. Here is a global accounting of these experiments.
Trial Launched to Treat Parkinson&rsquo;s with Reprogrammed Stem Cells
Trial Launched to Treat Parkinson’s with Reprogrammed Stem Cells
Diana Kwon | Jul 31, 2018
Surgeons will inject approximately 5 million dopamine-producing progenitor cells into patients’ brains.